November 18, 2026
Health news, explained with evidence
LIVE
Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia

Common Osteoporosis Medication Linked to Reduced Dementia Risk in New Study

❤️ Conditions & Care 2 min read 👁 9

Recent research examining medical records of over 120,000 older adults suggests a potential link between nitrogen-containing bisphosphonates and a lower incidence of dementia.

Common Osteoporosis Medication Linked to Reduced Dementia Risk in New Study❤️Conditions & Care

Photo: Women's Health

Key points

  • Study analyzed medical records of over 120,000 patients aged 60 and older.
  • Users of nitrogen-containing bisphosphonates showed a 24% lower dementia risk compared to those on other osteoporosis drugs.
  • Experts stress that further clinical trials are needed to prove direct causation.

A commonly prescribed class of osteoporosis medications known as nitrogen-containing bisphosphonates may offer a secondary benefit for cognitive health, according to an observational study published in the journal Alzheimer’s & Dementia. Researchers at the University of Hong Kong analyzed electronic medical records from more than 120,000 patients aged 60 and older who had osteoporosis or fragility fractures. The findings revealed that individuals using these bone-strengthening drugs experienced a 16 percent lower risk of developing Alzheimer's disease and related dementias compared to untreated peers, and a 24 percent lower risk when compared specifically to patients taking alternative osteoporosis treatments.

What to know: While the data highlights an intriguing correlation, specialists emphasize that this observational study does not prove causation. Experts note that improved bone health allows patients to maintain higher levels of physical activity, which naturally helps protect cognitive function. Additionally, researchers theorize that the medications might influence inflammation or neurodegenerative pathways, though randomized clinical trials are required to confirm these hypotheses.

Physicians do not currently recommend prescribing these drugs solely for dementia prevention. However, study co-author Ching-Lung Cheung, PhD, suggests the findings should reassure patients who need osteoporosis treatment that managing their bone health could potentially offer broader wellness benefits. Readers should consult a qualified healthcare provider for personalized medical decisions regarding treatment plans.

Source Women's Health — womenshealthmag.com/health/a74425105/osteoporosis-drug-dementia-ris… ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.